Renal Response After High-Dose Melphalan and Stem Cell Transplantation Is a Favorable Marker in Patients With Primary Systemic Amyloidosis

Cell Transplantation ◽

Systemic Amyloidosis ◽

High Dose ◽

Renal Response ◽

Acute renal insufficiency after high-dose melphalan in patients with primary systemic amyloidosis during stem cell transplantation

American Journal of Kidney Diseases ◽

10.1053/j.ajkd.2004.09.015 ◽

2005 ◽

Vol 45 (1) ◽

pp. 102-111 ◽

Cited By ~ 26

Author(s):

Nelson Leung ◽

Jeff M. Slezak ◽

Erik J. Bergstralh ◽

Angela Dispenzieri ◽

Martha Q. Lacy ◽

...

Keyword(s):

Stem Cell ◽

Renal Insufficiency ◽

Cell Transplantation ◽

Systemic Amyloidosis ◽

High Dose ◽

Acute Renal Insufficiency ◽

Predictive value of the new renal response criteria in AL amyloidosis treated with high dose melphalan and stem cell transplantation

American Journal of Hematology ◽

10.1002/ajh.25066 ◽

2018 ◽

Vol 93 (5) ◽

pp. E129-E132 ◽

Cited By ~ 1

Author(s):

Andrea Havasi ◽

Gheorghe Doros ◽

Vaishali Sanchorawala

Keyword(s):

Stem Cell ◽

Cell Transplantation ◽

Predictive Value ◽

Response Criteria ◽

High Dose ◽

Al Amyloidosis ◽

Renal Response ◽

Pathologic improvement after high-dose melphalan and autologous stem cell transplantation for primary systemic amyloidosis

Clinical Kidney Journal ◽

10.1093/ndtplus/sfn144 ◽

2008 ◽

Vol 1 (6) ◽

pp. 414-416 ◽

Cited By ~ 1

Author(s):

J. Hoshino ◽

Y. Ubara ◽

K. Ohashi ◽

F. Takemoto ◽

K. Takaichi

Keyword(s):

Stem Cell ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Systemic Amyloidosis ◽

High Dose ◽

High-dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative regimens for autologous stem cell transplantation in patients with multiple myeloma

Leukemia Research ◽

10.1016/j.leukres.2006.09.021 ◽

2007 ◽

Vol 31 (8) ◽

pp. 1069-1075 ◽

Cited By ~ 18

Author(s):

Don M. Benson ◽

Patrick J. Elder ◽

Thomas S. Lin ◽

William Blum ◽

Sam Penza ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

High Dose ◽

Busulfan, Melphalan, and Bortezomib versus High-Dose Melphalan as a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2016.03.021 ◽

2016 ◽

Vol 22 (8) ◽

pp. 1391-1396 ◽

Cited By ~ 19

Author(s):

Tulio E. Rodriguez ◽

Parameswaran Hari ◽

Patrick J. Stiff ◽

Scott E. Smith ◽

Danielle Sterrenberg ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Conditioning Regimen ◽

High Dose ◽

Hematopoietic Stem ◽

Duration of ulcerative mucositis and outcomes of autologous (AU) hematopoietic stem cell transplantation (HSCT) following high-dose melphalan (MP) conditioning for multiple myeloma (MM)

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2005.11.297 ◽

2006 ◽

Vol 12 (2) ◽

pp. 97

Author(s):

G. Oster ◽

M. Vera-Llonch ◽

C. Ford ◽

J. Lu ◽

I. Khazanov ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

High Dose ◽

Hematopoietic Stem ◽

Treatment of AL cardiac amyloidosis with intravenous high-dose melphalan and stem cell transplantation

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(02)80596-4 ◽

2002 ◽

Vol 39 ◽

pp. 136

Author(s):

Jina Chung ◽

Valshali Sanchorawala ◽

Martha Skinner ◽

Rodney H. Falk

Keyword(s):

Stem Cell ◽

Cell Transplantation ◽

Cardiac Amyloidosis ◽

High Dose ◽

Pegfilgrastim versus filgrastim to accelerate hematopoietic recovery after high-dose melphalan and autologous hematopoietic stem cell transplantation (ASCT) for multiple myeloma

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2004.12.257 ◽

2005 ◽

Vol 11 (2) ◽

pp. 87 ◽

Cited By ~ 1

Author(s):

R.L. Olin ◽

S.M. Luger ◽

D.L. Porter ◽

S.J. Schuster ◽

D. Tsai ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

High Dose ◽

Hematopoietic Stem ◽

Hematopoietic Recovery ◽

High Dose Melphalan and Autologous Stem Cell Transplantation (Hdm/Sct) for Treatment of Al Amyloidosis

Amyloid and Amyloidosis ◽

10.1201/9781420037494.ch54 ◽

2004 ◽

pp. 160-162

Author(s):

D Wright ◽

V Sanchorawala ◽

R Falk ◽

J Berk ◽

J Anderson ◽

...

Keyword(s):

Stem Cell ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

High Dose ◽

Al Amyloidosis ◽

Evaluation of pretransplant factors predicting cardiac dysfunction following high-dose melphalan conditioning and autologous peripheral blood stem cell transplantation

European Journal Of Haematology ◽

10.1111/j.1600-0609.2012.01815.x ◽

2012 ◽

Vol 89 (3) ◽

pp. 228-235 ◽

Cited By ~ 8

Author(s):

Jonathan S. Bleeker ◽

Morie A. Gertz ◽

Patricia A. Pellikka ◽

Dirk R. Larson ◽

Francis Buadi ◽

...

Keyword(s):

Stem Cell ◽

Cell Transplantation ◽

Peripheral Blood ◽

Cardiac Dysfunction ◽

Peripheral Blood Stem Cell ◽

Blood Stem Cell ◽

High Dose ◽

High Dose Melphalan ◽

Blood Stem Cell Transplantation